/ /

Laird Harrison
Laser system offers multiple treatments in single device
New laser technology in a single device offers multiple treatment platforms, including SLT for glaucoma, laser vitreolysis for floaters, capsulotomy, and iridotomy.
Retina geography not associated with cognitive decline
Retinal vascular changes do not show non-pathological age-related cognitive decline, researchers say. The study does not rule out the use of retinal information in diseases such as Alzheimer’s.
Real-world UK ranibizumab DMO outcomes match trials
Patients treated with ranibizumab (Lucentis, Genentech) for diabetic macular oedema (DMO) in the National Health Service of the United Kingdom can fare about as well as patients in clinical trials, a review of patient records suggests.
How genes may influence anti-VEGF treatment
Patients may respond differently to anti-vascular endothelial growth factor (VEGF) treatments for neovascular age-related macular degeneration (nAMD) depending on their genotypes, researchers say.
Drug therapies, delivery systems advance for glaucoma care
Pharmacologic products and devices in development continue to gain momentum in the glaucoma treatment armamentarium.
MIGS devices lead glaucoma surgical innovation in 2016
A single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent.
Researchers reject vitamin D role in macular degeneration
Researchers reject vitamin D role in macular degeneration
Analyzing data from the European Eye Study, Gareth J. McKay, PhD, of Queen’s University in Belfast, United Kingdom, and colleagues in 7 countries in Europe found no meaningful association between serum 25-hydroxy vitamin D (25(OH)D) and AMD. They published the finding in Ophthalmology.
Care lacking for diabetic eye diseases worldwide
Millions of adults around the world run the risk of losing their eyesight because of inattention to complications of diabetes, according to a team of international researchers. “A quarter of people with diabetes surveyed are not discussing eye complications with their health care professional, with many presenting when vision problems have already occurred,” the report said.
Eyecare providers criticized for blue light claims
Optical services chains in the United Kingdom are misleading customers about filters to screen out blue light from electronic devices, according to the BBC. Boots Opticians and Vision Express both claim that the filters protect against retinal damage despite a lack of evidence, the news service said in a recent press release.
Mediterranean diet may protect against macular degeneration
Mediterranean diet may protect against macular degeneration
The Mediterranean diet reduces the risk of age-related macular degeneration (AMD), according to a study of two Portuguese populations.


View Results